Rationale, study design and implementation of the COLM study: the combination of OLMesartan and calcium channel blocker or diuretic in high-risk elderly hypertensive patients
Kazuyuki Shimada(Nagoya University), Shigehiro Katayama(Institute for Advanced Study), Hiromi Rakugi(Osaka Rosai Hospital), Ikuo Saito(Shonan Institute of Technology), Kazuaki Shimamoto(Yakult Central Institute), Sadayoshi Ito(Tohoku University), Toshio Ogihara(Osaka University), Takao Saruta(Keio University), Tsutomu Imaizumi(Rohto Pharmaceutical (Japan)), Shuichi Takishita(University of the Ryukyus University Hospital), Jitsuo Higaki(Saiseikai Matsuyama Hospital), Masatsugu Horiuchi(Ehime University), Hiroaki Matsuoka(Social Welfare Department)
Cited by 169
Related Papers
Erratum: The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009)
|Hypertension Research|2014|1.4k
Morning Surge in Blood Pressure as a Predictor of Silent and Clinical Cerebrovascular Disease in Elderly Hypertensives
|Circulation|2003|1.2k
Transplanted cord blood–derived endothelial precursor cells augment postnatal neovascularization
|Journal of Clinical Investigation|2000|892
Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017
|Journal of Atherosclerosis and Thrombosis|2018|821